Rebecca Sharp
@reb_sharp
Vascular access device researcher
Was dir gefallen könnte
Do you want to do a fully funded PhD to improve one of the fastest growing sectors in health? 👇 Join us @RBRCUniSA for a project to develop better support mechanisms for caregivers of people having intravenous antibiotics at home. Further details here unisa.edu.au/research/degre…
Thank-you @Ch7Adelaide for allowing us to share the experience of these children and how to improve care. Hats off to the amazing FAAIRI service at Women's and Children's Hospital @amanda_ullman @TriciaVAMS @RBRCUniSA @UniversitySA 👏📷Catherine Miller and team
Vaccinations, blood tests, or IVs – it’s fair to say that no child likes a needle. Now, world-first research from the @UniversitySA is helping make the process easier and much less scary. youtu.be/GwTNIPYTL4U via @YouTube
Attending the 1st Australasian Nursing & Midwifery Clinical Trials Summit. We make up 60% of the registered health workforce. Our potential to lead research that improves patient care and outcomes is greatly underestimated. @CNMHSR_ECU @acn_tweet @marioneckert5 @anmctn
We are incredibly proud of AVAS members @a_ullman and @Claire_AVATAR on this outstanding achievement. This research will contribute to reducing CVC complications in children with cancer. Well done Amanda and Claire!
I am honoured & excited by the investment from @nhmrc as an IG to reduce CVC complications for kids w cancer & build capacity for the future. I am also excited that we get to DO the research, rather than PROPOSE the research, for the next 5 years. @UQHealth @childhealthqld
Supporting education & advanced practice for nurse practitioners wanting to learn DiVA US skills #acnp22 @acnp_national @AVASociety
Exciting news, look forward to working with @CVAACanada
Journal Alert! AVAS has partnered with the Canadian Vascular Access Association. AVAS Members can now disseminate their work and access a broader range of leading-edge theories, developments, research, and practices: avas.org.au/vascular-acces…
Journal Alert! AVAS has partnered with the Canadian Vascular Access Association. AVAS Members can now disseminate their work and access a broader range of leading-edge theories, developments, research, and practices: avas.org.au/vascular-acces…
Empowering patients to understand their PICC lines is important. Can assist with management at home and feeling comfortable living with.
PICC: catheter to vein ration (CVR) can increase thrombus risk. @reb_sharp suggests <45% CVR reduces risk. CVR >45% doubles risk.
Next speakers for the night Jacinta and Catherine
WCH FAARI service reducing multiple attempts for IV access. Provide advice service as well.
Kim presenting last session tonight
Kim’s research looking at adverse events of Umbilical Vein Catheters (UVC) and Umbilical Artery Catheters (UAC). Systematic review and meta analysis - adverse events UVC’s 13% UAC’s 9%
SA AVAS would like to thank @FloMedical for supporting our event this evening. Great turnout from clinicians interested in Vascular Access.
Free education in Adelaide, 'Improving vascular access device care across the age spectrum'. Register here: eventbrite.com/e/avas-adelaid…
AVAS members - @AlexandrouE & @AirliftNurse's recent presentations are now available on the website under the members portal! Check it out!
Free education event at UWS! Protocol based ultrasound assessment for venous and arterial access by @AirliftNurse & @AlexandrouE eventbrite.com.au/e/protocol-bas…
Congratulations to @UniversitySA's @profesterman for reaching 2 million all-time reads on his articles for @ConversationEDU! 🙌👏🎉
Awesome work cancer team!
United States Trends
- 1. Bovino N/A
- 2. Pro Bowl N/A
- 3. Homan N/A
- 4. Highguard N/A
- 5. Rising Stars N/A
- 6. El Centro N/A
- 7. Senator Young N/A
- 8. Sanders N/A
- 9. Louisville N/A
- 10. Hornets N/A
- 11. 3 Friday N/A
- 12. Geoff N/A
- 13. Joey Jones N/A
- 14. The Five N/A
- 15. The Atlantic N/A
- 16. Dance Tonight N/A
- 17. Luca N/A
- 18. Rigby N/A
- 19. Paul Newman N/A
- 20. Sal Buscema N/A
Something went wrong.
Something went wrong.